Brief Article Open Access
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 28, 2011; 17(16): 2131-2136
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2131
Ku80 gene G-1401T promoter polymorphism and risk of gastric cancer
Jia-Qi Li, Jie Chen, Nan-Nan Liu, Ying Zeng, Bin Wang, Xue-Rong Wang, Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
Li Yang, Department of General Surgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
Author contributions: Yang L, Zeng Y, Wang B and Wang XR designed the research and enrolled the patients; Li JQ, Chen J and Liu NN performed the research; Li JQ analyzed the data; Li JQ wrote the paper.
Supported by Grants from the National Natural Science Foundation of China, No. 30672486; the Natural Science Foundation of Jiangsu Province, No. BK2006525; “333 Project” and “Qinglan Project” Funds for the Young Academic Leader of Jiangsu Province to Wang B
Correspondence to: Xue-Rong Wang, PhD, Key Laboratory of Reproductive Medicine, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China. binwang@njmu.edu.cn
Telephone: +86-25-86862884 Fax: +86-25-86862884
Received: December 12, 2009
Revised: January 20, 2010
Accepted: January 27, 2010
Published online: April 28, 2011

Abstract

AIM: To evaluate the possible relationship between the Ku80 gene polymorphism and the risk of gastric cancer in China.

METHODS: In this hospital-based case-control study of gastric cancer in Jiangsu Province, China, we investigated the association of the Ku80 G-1401T (rs828907) polymorphism with gastric cancer risk. A total of 241 patients with gastric cancer and 273 age- and sex-matched control subjects were genotyped and analyzed by polymerase chain reaction-restriction fragment length polymorphism.

RESULTS: The frequencies of genotypes GG, GT and TT were 65.6%, 22.8% and 11.6% in gastric cancer cases, respectively, and 75.8%, 17.6% and 6.6% in controls, respectively. There were significant differences between gastric cancer and control groups in the distribution of their genotypes (P = 0.03) and allelic frequencies (P = 0.002) in the Ku80 promoter G-1401T polymorphism.

CONCLUSION: The T allele of Ku80 G-1401T may be associated with the development of gastric cancer.

Key Words: Ku80, Gastric cancer, Polymorphism, Promoter, Carcinogenesis



INTRODUCTION

Gastric cancer is one of the most frequent malignancies in many countries, accounting for 8.7% of all cancers and 10.4% of all cancer deaths in the year of 2000[1]. In China, gastric cancer remains the leading cause of cancer-related mortality among men and women[1,2]. It is estimated that about 39% of gastric cancer cases occur in Chinese population[1,2]. The environmental factors, diet, tobacco, alcohol and Helicobacter pylori infection are well-known causes of gastric cancer in China[3-5]. However, only a fraction of individuals exposed to these factors develop gastric cancer, suggesting that individual susceptibility to gastric cancer should be different. Currently, the genomic etiology of gastric cancer is of great interest but largely unknown.

DNA damage drives the formation and development of malignant tumors that ameliorate this damage, and its sequelae can be categorized as either gatekeeper or caretaker tumor suppressors, depending on their mode of action[6]. Nonhomologous end joining (NHEJ) repairs DNA double-strand breaks (DSBs) by joining ends without using a homologous template strand and has been described as a caretaker[7,8]. Many studies have shown that NHEJ is the predominant repair system in humans, which included the DNA ligase IV and its associated protein XRCC4, and the three components of the DNA-dependent protein kinase (DNA-PK) complex, Ku70, Ku80, and the catalytic subunit PKcs[9]. The Ku80 gene, also known as XRCC5, is an important and specific member of NHEJ. Ku70 and Ku80 form a heterodimer called Ku that is well known for its role in NHEJ pathway[10].

Ku acts as a regulator of transcription by interacting with the recombination signal binding protein Jκ and the nuclear factor (NF)-κB p50 homodimer to up-regulate p50 expression, which may regulate the proliferation of gastric cancer cells[11]. Gastric cancer cells with a low level of constitutive NF-κB had a lower expression level of Ku70 and Ku80, which was reflected in the lower nuclear levels of Ku proteins, than the wild-type cells and the cells transfected with control vector[12,13]. In addition, several studies reported that gastric cancer patients with a lower Ku80 expression level had a slightly prolonged survival after neoadjuvant chemotherapy[14-16].

Genetic polymorphisms in Ku80 genes influence DNA repair capacity and change predisposition of several cancers, including colorectal[17], bladder[18] and oral cancers[19]. In addition, in these hospital-based case-control studies of other cancers, it was reported that the frequency of GT/TT type of the Ku80 gene at promoter G-1401T (rs828907) was significantly higher in cases than in controls[17-19]. Thus, we assumed that the specific polymorphism of Ku80 gene may also contribute to gastric cancer. To test the hypothesis that the promoter G-1401T polymorphism is associated with the risk of gastric cancer, we used polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP) to genotype this polymorphism in a hospital-based case-control study of 241 patients with gastric cancer and 273 age- and sex-matched cancer-free controls. The results of this research will lead to a better understanding of the role of SNPs in the Ku80 genes in gastric cancer carcinogenesis. Such knowledge may eventually lead to the development of better preventive measures for gastric cancer.

MATERIALS AND METHODS
Study population

The case-control study consisted of 241 patients with gastric cancer and 273 cancer-free control subjects. The gastric cancer patients were confirmed histologically. Genetically unrelated cancer-free individuals were recruited as controls who were selected by matching for age and gender during the same period. All subjects were Han Chinese from the eastern region of China and randomly selected from the Department of General Surgery of the First Affiliated Hospital of Nanjing Medical University between 2005 and 2009. All patients and control subjects voluntarily participated in the study, completed a self-administered questionnaire and donated 5 mL of blood samples. The questionnaire included questions on sex, age, residence, diabetes, hypertension and smoking status. Smoking was defined as ≥ 10 cigarettes per day. This research protocol was approved by the Institutional Review Board of Nanjing Medical University.

Genotyping analysis

Genomic DNA was isolated from peripheral blood lymphocytes using standard phenol-chloroform extraction, as previously described[20,21]. PCR-RELP assay was used to type the Ku80 G-1401T (rs828907) polymorphisms. In brief, the primers of the Ku80 G-1401T polymorphism were 5'-TAGCTGACAACCTCACAGAT-3' (forward) and 5'-ATTCAGAGGTGCTCATAGAG-3' (reverse)[19], which generated a 252-bp fragment. The PCR reaction was performed in a total volume of 20 μL containing 2 μL 10 × PCR buffer, 1.25 mmol/L MgCl2, 0.1 mmol/L dNTPs, 0.25 μmol/L each primer, 200 ng of genomic DNA and 1 U of Taq DNA polymerase (MBI Fermentas). The PCR was performed at 94°C for 5 min and followed by 35 cycles of 30 s at 94°C, 30 s at 55°C and 30 s at 72°C, with a final elongation at 72°C for 10 min. The restriction enzyme BfaI (New England BioLabs) was used to distinguish the PCR product, and the genotypes were discriminated on 3% agarose gel and visualized by staining with 0.5 μg/mL ethidium bromide. The wild-type G-allele produced a single 252-bp fragment, and the polymorphic T-allele produced 2 fragments of 81-bp and 171-bp. Approximately, 10%-15% of the samples were randomly selected for repeated assays, and the results were 100% concordant.

Statistical analysis

Continuous variables are presented as mean ± SD and compared by unpaired Student’s t test. Continuous variables departing from the normal distribution were presented as median and interquartile range and analyzed by Mann-Whitney U-test. Discrete variables were represented as frequencies and percentages and evaluated by the Pearson’s χ2 test. Pearson’s χ2 test was also used to compare the distribution of the Ku80 genotypes between cases and controls. The association between the Ku80 G-1401T polymorphism and the risk of gastric cancer was estimated by odds ratio (OR) and 95% CI using multivariate logistic regression. P < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS version 13.0 for Windows (SPSS Inc., Chicago, IL, USA).

RESULTS
Baseline characteristics

The frequency distributions of selected characteristics of the cases and controls are presented in Table 1. There was no significant difference between the cases and controls in sex (male: 75.1% vs 70.7%, P = 0.43) and age (57.9 ± 12.9 years vs 56.9 ± 14.1 years, P = 0.52), indicating that the matching for the subjects was successful. More smokers were found among gastric cancer cases compared with controls (25.3% vs 14.3%, P = 0.014). No significant differences were noted in residing in the rural area (46.1% vs 52.0%, P = 0.32), hypertension (8.7% vs 10.3%, P = 0.58) and diabetes (6.2% vs 8.1%, P = 0.51).

Table 1 Baseline characteristics of cases and controls n (%).
CharacteristicsCases (n = 241)Controls (n = 273)P
Sex (male)181 (75.1)193 (70.7)0.43
Age (yr)57.9 ± 12.956.9 ± 14.10.52
Smoking61 (25.3)39 (14.3)0.014
Residence (rural)111 (46.1)142 (52.0)0.32
Hypertension21 (8.7)28 (10.3)0.58
Diabetes15 (6.2)22 (8.1)0.51
Genotype distributions and allele frequencies

Table 2 shows the distribution of the genotypic for the Ku80 G-1401T (rs828907) between gastric cancer patients and controls. The genotypic frequencies in both gastric cancer and control groups were in agreement with those predicted by Hardy-Weinberg equilibrium (P = NS). The distribution of the Ku80 G-1401T genotypes (GG, GT and TT) was markedly different between cases (65.6%, 22.8%, and 11.6%) and controls (75.8%, 17.6%, and 6.6%, P = 0.03). A significantly different distribution of the Ku80 G-1401T genotype was demonstrated among the cases and controls. As shown in Table 3, the frequency of T allele was significantly higher in gastric cancer patients than in control subjects (23.0% vs 15.4%, P = 0.002).

Table 2 Genotype of Ku80 G-1401T polymorphism in cases and controls n (%).
GenotypeCasesControl
GG158 (65.6)207 (75.8)
GT55 (22.8)48 (17.6)
TT28 (11.6)18 (6.6)
Table 3 Allele distribution of Ku80 G-1401T polymorphism in cases and controls n (%).
AlleleCasesControls
G371 (77.0)462 (84.6)
T111 (23.0)84 (15.4)
Stratified analyses for the variant Ku80 genotype in cases and controls

The multivariate logistic regression analysis was further used to evaluate the association between the G-1401T polymorphism and gastric cancer stratified by risk factors including age, sex, smoking and residence under control (Table 4). Adjusted OR (for age, sex, smoking status, residence, diabetes and hypertension) with 95% CI for mutant genotypes was all described. In statistical analyses stratified by the median age of controls (58 years), the increased risk associated with the GT/TT genotypes tended to be more evident in the younger subjects aged < 58 years (adjusted OR = 1.97, 95% CI: 1.05-2.90). However, we did not note a statistically significant inverse association with gastric cancer risk in older subjects aged ≥ 58 years (adjusted OR = 1.31, 95% CI: 0.88-1.96). The adjusted OR for the GT/GT genotypes was 1.81 (95% CI: 1.28-2.52) in male subjects and 1.33 (95% CI: 0.81-2.24) in female subjects. We did not note a statistically significant inverse association with gastric cancer risk in both non-smokers (adjusted OR = 1.48; 95% CI: 1.08-2.02) and smokers (adjusted OR = 2.52; 95% CI: 1.25-5.18). In urban subjects, there was significant evidence of an increased risk of gastric cancer in the variant genotypes (adjusted OR = 1.88; 95% CI: 1.26-2.76), while the association was not statistically significant in rural subjects (adjusted OR = 1.48; 95% CI: 0.99-2.15).

Table 4 Stratification analyses of the association between Ku80 polymorphism and risk of gastric cancer n (%).
VariableCases (n = 241)
Controls (n = 273)
Adjusted OR (95% CI)1P
GGGT + TTGGGT + TT
Age (yr) (median)
< 5876 (62.3)46 (37.7)109 (76.8)33 (23.2)1.97 (1.05-2.90)0.01
≥ 5882 (68.9)37 (31.1)98 (74.8)33 (25.2)1.31 (0.88-1.96)0.3
Sex
Male118 (65.2)63 (34.8)149 (77.2)44 (22.8)1.81 (1.28-2.52)0.01
Female40 (66.7)20 (33.3)58 (72.5)22 (27.5)1.33 (0.81-2.24)0.46
Smoking status
Smokers39 (63.9)22 (36.1)32 (82.1)7 (17.9)2.52 (1.25-5.18)0.051
Non-smokers119 (66.1)61 (33.9)175 (74.8)59 (25.2)1.48 (1.08-2.02)0.054
Residence
Urban85 (65.4)45 (34.6)102 (77.7)29 (22.3)1.88 (1.26-2.76)0.025
Rural73 (65.8)38 (34.2)105 (73.9)37 (26.1)1.48 (0.99-2.15)0.16
DISCUSSION

In this hospital-based, case-control study, we assessed the potential association between the Ku80 G-1401T polymorphism and the presence of gastric cancer in Chinese population. To our best knowledge, this is the first study linking the Ku80 G-1401T polymorphism with gastric cancer risk. Our data showed that the Ku80 -1401 G to T variant was associated with the increased risk of gastric cancer.

Gastric cancer is a genetic disease developing from a multifactorial, multigenetic and multistage process[22,23]. It was widely accepted that both genetic and environmental factors may be involved in the etiology of gastric cancer[24]. During the multistage carcinogenesis, Ku80 may be involved in multiple important cellular processes. To date, several studies have reported abnormal expression of Ku80 protein in various cancers[13,25-28]. Over-expression of Ku80 increased the capability of cancer acquired resistance to radiation and chemical drugs[29-31], while suppression of Ku80 expression decreased cellular proliferation, colony formation and inhibited tumorigenicity in a xenograft model[32]. As an important component of NHEJ, Ku80 and Ku70 form a heterodimer, which acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA[17]. The Ku80 gene plays an important and specific role in removing DSBs. Chang et al[18] found evidence that the Ku80 G-1401T variant was associated with increased risk of bladder cancer in a central Taiwanese population. A recent study, involving 362 patients with colorectal cancer and 362 age- and gender-matched healthy controls, showed that the T allele Ku80 G-1401T conferred a significantly (P = 0.0069) increased risk of colorectal cancer[17]. These observations were consistent with the findings previously described by other investigators from Asian populations[19].

To further investigate the association between the Ku80 promoter G-1401T polymorphism and the risk of gastric cancer, we conducted this hospital-based case-control study in a Chinese population which incorporated the information on exposure to smoking, residence and other potential confounding factors (age and sex) that were frequency matched between cases and controls and further adjusted in the analysis. In our study, a significant difference of the Ku80 G-1401T genotype distribution was found between gastric cancer cases and controls. The frequency of T allele was significantly higher in gastric cancer patients than in control subjects.

The precise mechanisms underlying the relationship between Ku80 polymorphism and stomach carcinogenesis remain unclear. Although the Ku80 promoter G-1401T genetic variation does not directly lead to amino acid coding change, presumably, it is plausible that this SNP influences the expression level or stability of the Ku80 protein by the alternative spicing, intervention, modification, determination or involvement. It is similar to another important member of NHEJ, XRCC4. A few reports provided evidence that its SNPs located on the promoter region are significant in various cancers[33,34].

Our data also showed that the association between increased gastric cancer risk and the mutant genotypes (GT + TT) was more evident in younger subjects aged < 58 years than in older subjects. We also found an interaction between genotype and sex. The adjusted OR was 1.81 (95% CI: 1.28-2.52) for GT/TT genotype compared with GG genotype among male subjects. But the OR (adjusted OR = 1.33; 95% CI: 0.81-2.24) was not statistically significant among female subjects. Our findings were inconsistent with previous observations by Yang et al[17] and Chang et al[18]. The reason for the different observations remains unclear.

In addition, we did not note a statistically significant inverse association with gastric cancer risk in both non-smokers (adjusted OR = 1.48; 95% CI: 1.08-2.02) and smokers (adjusted OR = 2.52; 95% CI: 1.25-5.18). But Yang et al[17] reported that the GT and TT genotypes, in association with smoking, conferred an increased risk (adjusted OR = 2.537; 95% CI: 1.398-4.601) for colorectal cancer. Similarly, Chang et al[18] and Hsu et al[19] found a significantly decreased risk of bladder cancer (adjusted OR = 2.053; 95% CI: 1.232-3.419) and oral cancer in smokers with GT or TT genotypes[18,19]. The results are inconsistent with our findings. The reason for the different observations remains unclear. Several studies have reported that smoking is associated with free radical-induced DNA damage and strand breaks[26], and tobacco smoke contains some potential carcinogens including polycyclic aromatic hydrocarbons, tobacco nitro-amines, aromatic amines and BPDE, which form DNA bulky adducts and DNA strand breaks[27,35].

The stratified analyses by residence revealed that the association was significant in variant genotypes in urban subjects (OR = 1.88; 95% CI: 1.26-2.76) but not in rural subjects (adjusted OR = 1.48; 95% CI: 0.99-2.15). The different results may be explained, at least in part, between rural and urban subjects. Environmental factors, including air, soil, diet, occupation and lifestyle, may be responsible for the different observations between rural and urban subjects. It was plausible, considering the better environment in rural areas[36].

The potential limitations of the present study should be stressed. Firstly, in this hospital-based case-control study, we selected controls from individuals with a variety of nonmalignant diseases. These may cause the possibility of selection bias and confound the results. Nevertheless, the frequencies of Ku80 G-1401T polymorphism variant alleles were similar to those reported in the NCBI Website in the Asian population studies. T allele frequencies of Ku80 promoter G-1401T are 15.4% in our control group and 17.4% for Asian population in NCBI. The genotype distribution of controls in our study met Hardy-Weinberg equilibrium conditions. Secondly, the sample size of the present study was relatively small, which may limit the statistical power. Finally, our study was conducted in Chinese population. Caution should be exercised when extrapolating the data to other ethnic groups.

In conclusion, we found a significant difference in the Ku80 G-1401T polymorphism distribution between the patients with gastric cancer and the control group. The T allele of the Ku80 G-1401T was found more frequently in patients with gastric cancer and it may be associated with an increased risk of gastric cancer, suggesting that the polymorphism of Ku80 G-1401T, involved in the gastric tract carcinogenesis, may be a useful marker for primary prevention and anticancer intervention. Further studies are needed to determine the exact nature of this relationship.

COMMENTS
Background

The Ku80 gene is an important and specific member of NHEJ. Genetic polymorphisms in Ku80 genes (G-1401T) influence DNA repair capacity and change the predisposition of several cancers, including colorectal, bladder and oral cancer. Whether genetic variants are involved in the risk of gastric cancer in a Chinese population is unknown.

Research frontiers

In this study, the frequency of the Ku80 G-1401T GT/TT genotypes was significantly higher in the gastric cancer patients than in control subjects. This is the first analysis of the association between genetic predisposition and gastric cancer risk in Chinese population.

Innovations and breakthroughs

The Ku80 G-1401T polymorphisms may modulate the development of gastric cancer in a Chinese population.

Applications

The Ku80 G-1401T GT/TT genotypes can be used as biomarkers for selecting patients from the individuals at high risk for gastric cancer in China. Identifying such susceptibility polymorphisms may lead to the development of tests that allow more focused follow-ups of high-risk groups.

Terminology

The Ku80 gene, also known as XRCC5, is an important and specific member of NHEJ. As an important component of NHEJ, Ku80 and Ku70 form a heterodimer, which acts as a regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA.

Peer review

The quality of the work and the methodology are sound. The conclusions are appropriate, although it seems unlikely that these findings represent a major breakthrough.

Footnotes

Peer reviewer: Pete Muscarella, MD, Division of Gastrointestinal Surgery, The Ohio State University, N711 Doan Hall, 410 W. 10th Ave., Columbus, OH 43210, United States

S- Editor Wang YR L- Editor Ma JY E- Editor Zheng XM

References
1.  Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-543.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW, Huangfu XM, Sun J, Li LD, Lu FZ, Qiao YL. [Analysis of mortality rate of stomach cancer and its trend in twenty years in China]. Zhonghua Zhongliu Zazhi. 2004;26:4-9.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Takezaki T, Gao CM, Ding JH, Liu TK, Li MS, Tajima K. Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China; with special reference to allium vegetables. J Epidemiol. 1999;9:297-305.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Galanis DJ, Lee J, Kolonel LN. The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer. 1997;79:1840-1841.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer. 2003;103:815-821.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 1997;386:761, 763.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Roth DB, Gellert M. New guardians of the genome. Nature. 2000;404:823-825.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst). 2006;5:1042-1048.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23:687-696.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Liang F, Romanienko PJ, Weaver DT, Jeggo PA, Jasin M. Chromosomal double-strand break repair in Ku80-deficient cells. Proc Natl Acad Sci USA. 1996;93:8929-8933.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Kim H. DNA repair Ku proteins in gastric cancer cells and pancreatic acinar cells. Amino Acids. 2008;34:195-202.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Lim JW, Kim H, Kim KH. The Ku antigen-recombination signal-binding protein Jkappa complex binds to the nuclear factor-kappaB p50 promoter and acts as a positive regulator of p50 expression in human gastric cancer cells. J Biol Chem. 2004;279:231-237.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Lim JW, Kim H, Kim KH. Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J Biol Chem. 2002;277:46093-46100.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Napieralski R, Ott K, Kremer M, Specht K, Vogelsang H, Becker K, Müller M, Lordick F, Fink U, Rüdiger Siewert J. Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients. Clin Cancer Res. 2005;11:3025-3031.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Höfler H, Langer R, Ott K, Keller G. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. Adv Exp Med Biol. 2006;587:115-120.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Höfler H, Langer R, Ott K, Keller G. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. Recent Results Cancer Res. 2007;176:33-36.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Yang MD, Hsu YM, Kuo YS, Chen HS, Chang CL, Wu CN, Chang CH, Liao YM, Wang HC, Wang MF. Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. Anticancer Res. 2009;29:2239-2242.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Chang CH, Chiu CF, Liang SY, Wu HC, Chang CL, Tsai CW, Wang HC, Lee HZ, Bau DT. Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res. 2009;29:1275-1279.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, Tsai MH, Bau DT. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol. 2009;45:789-793.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis. 2006;27:2491-2496.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Wang LS, Tang NP, Zhu HJ, Zhou B, Yang L, Wang B. Endothelin-converting enzyme-1b C-338A polymorphism is associated with the increased risk of coronary artery disease in Chinese population. Clin Chim Acta. 2007;384:75-79.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58-60.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Gao L, Nieters A, Brenner H. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther. 2008;28:565-573.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Crandall WV, Mackner LM. Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model. Aliment Pharmacol Ther. 2003;17:75-84.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Tonotsuka N, Hosoi Y, Miyazaki S, Miyata G, Sugawara K, Mori T, Ouchi N, Satomi S, Matsumoto Y, Nakagawa K. Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int J Mol Med. 2006;18:441-447.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Korabiowska M, Voltmann J, Hönig JF, Bortkiewicz P, König F, Cordon-Cardo C, Jenckel F, Ambrosch P, Fischer G. Altered expression of DNA double-strand repair genes Ku70 and Ku80 in carcinomas of the oral cavity. Anticancer Res. 2006;26:2101-2105.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Hosoi Y, Matsumoto Y, Enomoto A, Morita A, Green J, Nakagawa K, Naruse K, Suzuki N. Suramin sensitizing cells to ionizing radiation by inactivating DNA-dependent protein kinase. Radiat Res. 2004;162:308-314.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Chen TY, Chen JS, Su WC, Wu MS, Tsao CJ. Expression of DNA repair gene Ku80 in lymphoid neoplasm. Eur J Haematol. 2005;74:481-488.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Wilson CR, Davidson SE, Margison GP, Jackson SP, Hendry JH, West CM. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer. 2000;83:1702-1706.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K, Hamakawa H. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci. 2003;94:894-900.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Chang HW, Kim SY, Yi SL, Son SH, Song do Y, Moon SY, Kim JH, Choi EK, Ahn SD, Shin SS. Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck. Oral Oncol. 2006;42:979-986.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Yang QS, Gu JL, Du LQ, Jia LL, Qin LL, Wang Y, Fan FY. ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines. J Radiat Res (Tokyo). 2008;49:399-407.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, Bau DT. A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol. 2008;15:514-518.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC, Bau DT. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol. 2008;44:898-902.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Leanderson P, Tagesson C. Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation. Chem Biol Interact. 1992;81:197-208.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Wu MS, Chen CJ, Lin JT. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878-1882.  [PubMed]  [DOI]  [Cited in This Article: ]